ESR1 and breast neoplasm: Of interest, retrospective Kaplan–Meier analysis of expression cohorts of breast tumor showed that low miR-125a-5p expression levels correlate with poor overall survival in tamoxifen-treated ER+ breast cancer patients (Figure 6F).